Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China

This pilot study assesses the safety and efficacy of once-daily, oral levofloxacin monotherapy in Chinese patients with low-risk febrile neutropenia. In this prospective, single-arm, open-label, multicenter clinical trial, 46 adult Chinese patients with solid tumors and low-risk febrile neutropenia...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lixian, Zhou, Caicun, Zhao, Su, Weng, Heng, Yang, Guowang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314102/
https://www.ncbi.nlm.nih.gov/pubmed/25486597
http://dx.doi.org/10.1097/CAD.0000000000000187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314102/
https://www.ncbi.nlm.nih.gov/pubmed/25486597
http://dx.doi.org/10.1097/CAD.0000000000000187

Ejemplares similares